Laserfiche WebLink
STAFF RECOMMENDATION <br /> Staff recommends the Planning Commission: <br /> 1 . Find that the proposed project would not have a significant effect on the environment. <br /> 2. Find that the proposed PUD Rezoning and Development Plan are consistent with the <br /> General Plan. <br /> 3. Find that the proposed Development Agreement is consistent with the General Plan. <br /> 4. Adopt a resolution recommending adoption of the Draft IS/MND. <br /> 5. Adopt a resolution making the PUD findings and recommending approval of Cases PUD- <br /> 139 and P20-0973, subject to the draft conditions of approval listed in Exhibit A2. <br /> 6. Adopt a resolution recommending finding the Development Agreement is consistent with <br /> the General Plan. <br /> 7. Forward the IS/MND, Cases PUD-139 and P20-0973, and the Development Agreement to <br /> the City Council for consideration. <br /> EXECUTIVE SUMMARY <br /> The subject applications propose to: (1) rezone the subject parcel from C-R (p) (Regional <br /> Commercial - peripheral sites) District to PUD-C-O (Planned Unit Development — Commercial- <br /> Office) District; (2) construct up to three new multi-story research and development, office and <br /> laboratory buildings totaling approximately 381,000 square feet, a parking structure, and <br /> related site improvements over multiple phases; as well as (3) make a finding of General Plan <br /> conformity for a related Development Agreement to vest the entitlements for the project. PUD <br /> Rezoning and Development Plan applications are required, since the proposed mix of land <br /> uses are not expressly allowed by the current zoning, and the planned master campus layout <br /> of the proposed site improvements require flexibility and relief from the prescribed <br /> development standards of the current zoning district which are typically considered on a case- <br /> by-case basis pursuant to the Pleasanton Municipal Code (PMC). The applications were <br /> previously reviewed by the Planning Commission as a work session item on November 18, <br /> 2020. The applications presented herein have been revised to reflect the comments received <br /> at the work session. The applications are now before the Planning Commission for a <br /> recommendation to the City Council for consideration. <br /> BACKGROUND <br /> Zoning and General Plan <br /> The subject site is zoned C-R (p) District and has a General Plan Land Use designation of <br /> Retail/Highway/Service Commercial Business and Professional Offices. Research & <br /> Development (R&D) and laboratory uses are not separately defined or identified as a land use <br /> category in the PMC; however, both are listed among a broad range of potential uses in the <br /> PMC's definition of "Light Industrial." R&D and laboratory uses are not expressly permitted in <br /> the C-R (p) District; thus, PUD Rezoning to a more flexible zoning category, for which the <br /> types and parameters of allowable uses would be specified, is required. The office uses <br /> proposed would be permitted under the current and proposed zoning districts. <br /> The General Plan indicates the average allowable development density/intensity, expressed as <br /> Floor Area Ratio (FAR), is 35-percent with a maximum FAR of 60-percent. Program 15.5 of the <br /> Land Use Element in the General Plan indicates industrial, retail, and office projects should <br /> conform to the average density assumed (i.e., 35-percent FAR). However, projects may be <br /> allowed up to the maximum (i.e., 60-percent FAR) provided sufficient amenities and mitigations <br /> are incorporated into the project to justify the increased density. Additionally, page 24 of the <br /> PUD-139 and P20-0973, 10x Genomics, Inc. Planning Commission <br /> 2 of 32 <br /> -8- <br />